According to a newly published market research report by 24LifeSciences, the global BNCT boron drug market was valued at USD 72 million in 2024 and is projected to reach USD 160 million by 2031, growing at a compound annual growth rate (CAGR) of 12.3% during the forecast period. BNCT boron drugs comprise highly specialized pharmaceutical agents designed to selectively deliver boron-10 isotopes...